Medical Abortion Clinical Trial
Official title:
Comparison of the Safety, Efficacy, and Feasibility of Medical Abortion Provided by Physicians and Non-physicians in Nepal: a Randomized Controlled, Equivalence Trial.
The purpose of the study is to compare the safety, effectiveness, and acceptability of medical abortion provided by doctors and midlevel providers in a developing country where doctors are scarce, such as Nepal. This study is the first to evaluate the independent provision of medical abortion by trained nurses and auxiliary nurse midwives compared to doctors by assessing differences in safety, clinical outcomes, case management decision-making, and acceptability. This study provides scientifically valid data on the administration of medical abortion by midlevel providers working independently in a low-resource, developing country setting. The evidence generated by the study will assist policy makers in developing countries interested in expanding safe abortion services by eliminating the legal requirement limiting prescription of medical abortion to doctors where medical abortion is not restricted by law.
Each year, some 210 million women throughout the world become pregnant and nearly one in
five chooses to terminate the pregnancy (Singh et al., 2009). Approximately, 22 million
pregnancies are terminated unsafely; of these, the vast majority (98%) take place in
developing countries (WHO, Forthcoming). Access to safe abortion services is a challenge for
many women with unwanted pregnancies in developing countries because of restrictive
legislation, a shortage of skilled staff or other barriers.
Non-surgical methods of abortion, known as medical abortion, have been developed that use
safe and effective drug-based methods for induced abortion. Prescribing authority is
generally limited to doctors, however. As a result, medical abortion remains under-utilized
and is often inaccessible for many women in developing countries seeking public sector
providers trained in medical abortion in areas where there are no doctors.
Midlevel providers (non-physician clinicians such as nurses and midwives) have the potential
to provide accessible, low-cost, and safe abortion services in many countries, especially in
the developing world. They are more cost-effective to employ than doctors and often work in
areas where doctors are in short supply, providing much needed health services to
under-served areas while conserving resources. Training midlevel providers in the
independent provision of medical abortion with appropriate referral systems would expand
access to safe abortion services to lower levels of the health care system where there is no
doctor and complement a global health systems trend towards task-shifting where doctors are
costly and scarce (WHO, 2007).
The overall objective of the study is to obtain evidence on the safety and effectiveness of
medical abortions performed by government trained and certified midlevel providers and
physicians to inform policy makers interested in or committed to expanding and
decentralizing medical abortion services.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT02745093 -
Medical Abortion at Gestational Age of 8 to ≤9 Weeks Versus >9 to ≤12 Weeks
|
Phase 4 | |
Completed |
NCT02570204 -
Self-Assessment of Medical Abortion Outcome Using Serial Multi-level Pregnancy Tests
|
N/A | |
Completed |
NCT01487213 -
Routine Follow-up Versus Self-assessment in Medical Abortion
|
N/A | |
Terminated |
NCT05119439 -
Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks
|
Phase 4 | |
Terminated |
NCT04941443 -
Methadone and Medication Abortion
|
Phase 4 | |
Completed |
NCT02985229 -
Acceptability and Feasibility of Medical Abortion in Singapore
|
Phase 3 | |
Completed |
NCT01920022 -
Quickstart of Nexplanon® at Medical Abortion
|
Phase 4 | |
Completed |
NCT00472394 -
Determining Women's Preferences for Medical Abortion Using Willingness to Pay
|
N/A | |
Completed |
NCT03604341 -
Cannabinoids for Pain Control During Medical Abortion
|
Phase 4 | |
Completed |
NCT00907725 -
Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?
|
N/A | |
Completed |
NCT00120224 -
De-Medicalizing Mifepristone Medical Abortion
|
N/A | |
Completed |
NCT03148587 -
Medical Abortion Self-Confirmation (MASC)
|
N/A | |
Completed |
NCT00621543 -
Insertion of an Intrauterine Device (IUD) After Medical Abortion
|
N/A | |
Completed |
NCT02343913 -
Simplifying Menstrual Regulation (MR): Post Abortion Care in Pakistan
|
N/A | |
Completed |
NCT01856777 -
Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy
|
N/A | |
Recruiting |
NCT00920465 -
Treatment Regimens for Mifegyne and Cytotec
|
Phase 3 | |
Completed |
NCT05532085 -
Assessment of Pain During an Abortion With Knowledge of the Predictive Factors of Pain.
|
||
Completed |
NCT00997347 -
The Extended Gestational Age Medical Abortion Study
|
Phase 4 | |
Completed |
NCT03014193 -
Simplifying First Trimester Medical Abortion Follow-up
|
N/A | |
Recruiting |
NCT04905251 -
Effectiveness and Safety of Combination Mifepristone/Misoprostol for Medical Abortion
|